Roche and Genentech warn of counterfeit Avastin

02/14/2012 | Reuters · Wall Street Journal, The

Roche Holding and its unit Genentech reported that a fake version of their injectable cancer drug Avastin was found in the U.S. The FDA is investigating and has alerted medical practices about the counterfeit product.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Actuary
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL